Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

President Signs into Law the Cybersecurity Information Sharing Act of 2015

Publications

December 23, 2015

After months of deliberation (see our April 23 and October 28 alerts), President Obama signed into law the consolidated version of the Cybersecurity Information Sharing Act of 2015 (CISA) as part of the massive omnibus spending bill. The final version of CISA will establish a process allowing participating businesses to share certain cyberthreat information with the federal government and vice versa. These businesses are incentivized to participate in the form of liability protection from lawsuits for sharing such cyberthreat information. CISA tasks the Department of Homeland Security (DHS) with the responsibility of acting as the intermediary between the federal government and participating businesses and also requires DHS to establish an automated system for sharing in real time any provided cyberthreat information with other governmental agencies.

While CISA is still in its nascent stages, most business groups generally support the legislation and its potential to improve prevention, detection, and mitigation of cybersecurity threats.  However, some consumer advocates continue to argue that CISA provides limited privacy protections to Americans, though the final version of CISA does require the removal of personally identifiable information from data before such data is shared.

Bass, Berry & Sims will continue to monitor and provide updates as we track cybersecurity legislation. If you have questions regarding the potential effects of this legislation, or any other cybersecurity concerns related to your organization, please contact an attorney on our Data Security & Privacy Team.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.